Celera Genomics

Celera Genomics (NYSE:CRA), an Applera Corporation business, has a highly accurate and sensitive test used for genotyping of the hepatitis C virus (HCV) which has received approval to CE Mark the RealTime™ HCV Genotype Assay, which allows it to be marketed in the European Union as a diagnostic product. This is designed for use on the automated ABI PRISM® 7000 real-time PCR (polymerase chain reaction) system from Applied Biosystems

Further Information: http://www.celera.com/